3 completed. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
Follow CLL (Chronic Lymphocytic Leukemia): new trials by email Literature Review of CLL (Chronic Lymphocytic Leukemia) trials Research Report on CLL (Chronic Lymphocytic Leukemia)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Improving Blood Stem Cell Collection and Transplant Procedures Stem Cell Transplantation - Myelodysplastic Syndrome (MDS), Chronic Myelogenous Leukemia | Phase 1 / Phase 2 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 43 | 2012-01-13 | 2018-07-05 |
| Ofatumumab-based Induction Chemoimmunotherapy in Previously Untreated Patients With CLL/SLL Fludarabine Phosphate, Ofatumumab, Cyclophosphamide - Small Lymphocytic Lymphoma, CLL (Chronic Lymphocytic Leukemia) | Phase 2 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 32 | 2010-07-01 | 2023-11-28 |
| Stem Cell Transplantation for Patients With Cancers of the Blood Miltenyi system - CML (Chronic Myelogenous Leukemia), CLL (Chronic Lymphocytic Leukemia) | Phase 2 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 61 | 2007-04-01 | 2018-07-13 |
Leukemia, B-Cell (3) · Leukemia (2) · Leukemia, Lymphocytic, Chronic, B-Cell (2) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (2) · Myelodysplastic Syndromes (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Anemia, Refractory, with Excess of Blasts (1) · Leukemia, Myeloid, Acute (1)
Chronic Disease (3) · Disease Attributes (3) · Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Leukemia, Lymphoid (3) · Lymphatic Diseases (3) · Lymphoproliferative Disorders (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Bone Marrow Diseases (2) · Leukemia, Myeloid (2)
Cyclophosphamide (1) · Stem Cell Transplantation (1) · fludarabine phosphate (1) · ofatumumab (1)
National Heart, Lung, and Blood Institute (NHLBI) (3)
United States (3)
Minocher M Battiwalla, M.D. (2) · Inhye Ahn, M.D. (1)